Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Intestinal Neoplasms

quinazolines has been researched along with Intestinal Neoplasms in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernards, N; Creemers, GJ; de Hingh, IHJT; Legué, LM; Lemmens, VEPP; van Erning, FN1
Clarke, AR; Maughan, TS; Shaw, PH1
Brun, Y; Greco, WR; Slocum, HK; White, DB; Wrzosek, C1
Berger, FG; Davis, C; Murphy, JT; Tucker, JM1
Alferez, D; Goodlad, RA; Mandir, N; Poulsom, R; Pyrah, IT; Ryan, AJ; Smith, NR; Watkins, AJ; Wedge, SR; Wilkinson, RW1
Erbeck, D; Qazi, S; Tibbles, HE; Uckun, FM; Vassilev, A; Venkatachalam, T1
Cao, S; Rustum, YM; Yin, MB1
Ferone, R; Hanlon, MH1

Other Studies

8 other study(ies) available for quinazolines and Intestinal Neoplasms

ArticleYear
Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study.
    Targeted oncology, 2019, Volume: 14, Issue:6

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Female; Fluorouracil; Humans; Intestinal Neoplasms; Intestine, Small; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Netherlands; Organoplatinum Compounds; Oxaliplatin; Palliative Care; Prognosis; Quinazolines; Registries; Retrospective Studies; Survival Rate

2019
Dual inhibition of epidermal growth factor and insulin-like 1 growth factor receptors reduce intestinal adenoma burden in the Apc(min/+) mouse.
    British journal of cancer, 2011, Aug-23, Volume: 105, Issue:5

    Topics: Adenoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Down-Regulation; Drug Evaluation, Preclinical; Drug Synergism; ErbB Receptors; Gefitinib; Genes, APC; Intestinal Neoplasms; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Protein Kinase Inhibitors; Pyrimidines; Quinazolines; Receptor, IGF Type 1; Tumor Burden

2011
A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example.
    Current drug metabolism, 2003, Volume: 4, Issue:5

    Topics: Adenocarcinoma; Algorithms; Antimetabolites; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Humans; Hydroxymethyl and Formyl Transferases; Intestinal Neoplasms; Models, Biological; Nonlinear Dynamics; Phosphoribosylglycinamide Formyltransferase; Quinazolines; Tetrahydrofolates; Thiophenes; Trimetrexate

2003
Raltitrexed increases tumorigenesis as a single agent yet exhibits anti-tumor synergy with 5-fluorouracil in ApcMin/+ mice.
    Cancer biology & therapy, 2004, Volume: 3, Issue:11

    Topics: Adenoma; Adenomatous Polyposis Coli Protein; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Epithelial Cells; Female; Fluorouracil; Intestinal Neoplasms; Loss of Heterozygosity; Male; Mice; Mice, Inbred C57BL; Quinazolines; Thiophenes; Tumor Burden

2004
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.
    Carcinogenesis, 2006, Volume: 27, Issue:10

    Topics: Adenoma; Animals; Female; Genes, APC; Intestinal Neoplasms; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Quinazolines; RNA, Messenger; Signal Transduction; Splenomegaly; Vascular Endothelial Growth Factor Receptor-2

2006
Effect of targeting janus kinase 3 on the development of intestinal tumors in the adenomatous polyposis coli(min) mouse model of familial adenomatous polyposis.
    Arzneimittel-Forschung, 2007, Volume: 57, Issue:6

    Topics: Adenomatous Polyposis Coli; Animals; beta Catenin; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Intestinal Neoplasms; Janus Kinase 3; Male; Mice; Mice, Inbred C57BL; Point Mutation; Quinazolines; Survival Analysis; Tissue Distribution

2007
Modulation of target enzyme associated with the action of antifolates.
    Advances in enzyme regulation, 1994, Volume: 34

    Topics: Antimetabolites, Antineoplastic; Carcinoma; Dose-Response Relationship, Drug; Drug Interactions; Evaluation Studies as Topic; Humans; Intestinal Neoplasms; Leucovorin; Quinazolines; Thiophenes; Thymidine; Thymidylate Synthase; Tumor Cells, Cultured

1994
In vitro uptake, anabolism, and cellular retention of 1843U89 and other benzoquinazoline inhibitors of thymidylate synthase.
    Cancer research, 1996, Jul-15, Volume: 56, Issue:14

    Topics: Animals; Carcinoma; Enzyme Inhibitors; Folic Acid; Folic Acid Antagonists; Humans; Indoles; Intestinal Neoplasms; Isoindoles; Leucovorin; Liver; Metabolic Clearance Rate; Peptide Synthases; Polyglutamic Acid; Quinazolines; Swine; Thymidylate Synthase; Tumor Cells, Cultured

1996